Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma

Aguiar, T., Mashiko, S., Asam, K., Roy, P., Wang, S., Frank, K., Dietzel, M., Schahadat, L. G. Z., Ausmeier, M., Hertel, A., Duan, Z. R. S., Aouizerat, B., Genkinger, J. M., Remotti, H., & Zorn, E. (2025). Development of high-titer class-switched antibody responses to phosphorylated amino acids is prevalent in pancreatic ductal adenocarcinoma. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1501943
Authors:
Talita Ferreira Marques Aguiar
Shunya Mashiko
Kesava Asam
Poulomi Roy
Shikun Wang
Katharina Frank
Max Dietzel
Luca G. Z. Schahadat
Mattea Ausmeier
A. Hertel
Zhijian Duan
Bradley E. Aouizerat
Jeanine M. Genkinger
Helen Remotti
Emmanuel Zorn
Affiliated Authors:
Talita Ferreira Marques Aguiar
Shunya Mashiko
Poulomi Roy
Shikun Wang
Katharina Frank
Max Dietzel
Luca G. Z. Schahadat
Mattea Ausmeier
A. Hertel
Zhijian Duan
Jeanine M. Genkinger
Emmanuel Zorn
Columbia Affiliation:
Subjects:
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
Glycosylation in Health and Disease (OpenAlex Topic)
Epidemiology and Management of Neuroendocrine Tumors (OpenAlex Topic)
Author Keywords:
pancreatic ductal adenocarcinoma
antibody responses
phosphoryl adducts
phosphoproteome
elisa
elink
Publication Type:
Article
Unique ID:
10.3389/fimmu.2025.1501943
PMID:
40226613
DOI:
10.3389/fimmu.2025.1501943
Journal:
Frontiers in Immunology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View Web of Science Record

Record Created: